Comparative Studying of Human Cord Blood Components Antiviral Activity at Experimental Grippe Viral Infection

Authors

  • E. S. Onasenko Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkov
  • E. V. Brovko Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkov
  • L. V. Stepanyuk Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkov
  • V. L. Ponomareva Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkov

Keywords:

cord blood, antiviral effect, hemagglutination titre

Abstract

Comparative studying of human cord blood leucoconcentrate and its components antiviral activity was carried out. It was established that the highest inhibiting activity possessed human cord blood leucoconcentrate and plasma. This allows to assume their usage for grippe virus diseases prophylaxis. The further research of leucoconcentrate antiviral activity is necessary for final judgement its efficiency as a nonspecific antiviral protective preparation.

Downloads

Published

2008-12-22

How to Cite

Onasenko, E. S., Brovko, E. V., Stepanyuk, L. V., & Ponomareva, V. L. (2008). Comparative Studying of Human Cord Blood Components Antiviral Activity at Experimental Grippe Viral Infection. Problems of Cryobiology and Cryomedicine, 18(4), 527–530. Retrieved from https://cryo.org.ua/journal/index.php/probl-cryobiol-cryomed/article/view/369

Issue

Vol. 18 No. 4 (2008): Problems of Cryobiology

Section

Conference Papers

License

Copyright (c) 2020 E. S. Onasenko, E. V. Brovko, L. V. Stepanyuk, V. L. Ponomareva

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).